Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates?

By D. Dohan, J. Choukroun, A. Diss, Steve L Dohan, A. Dohan, J. Mouhyi, B. Gogly. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2006

806 citations recorded by the source corpus.

Subfields: Hematology, Surgery, Urology

View Paper: https://www.semanticscholar.org/paper/7d47529371b13f776d12e81bb9bad50d84b7fbf4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hematology

1. P. Doglioli
2. D. M. Dohan Ehrenfest
3. G. Sammartino
4. G. M. de Peppo

In Urology

1. P. Doglioli
2. D. M. Dohan Ehrenfest
3. G. Sammartino
4. G. M. de Peppo

Citations in the corpus

• Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies (2009, methodology): “Previous studies suspected this phenomenon with indirect proofs (Dohan et al. 2006a,b): after quantification of many different residual cytokines (growth factors and interleukins) within the supernatant and the clot exudate soon after PRF preparation, the cytokine amounts were found very low in…”